Research on vaccines and immunization. Covers COVID and flu vaccines, outbreak response, long-lasting antibodies, and vaccination in vulnerable groups.
Researchers developed a conjugate vaccine that stimulates strong immune responses and neutralizes bacteria, providing protection to newborns. The study found that antibodies isolated from immunized women can cross the placenta and protect infants from infection.
Researchers successfully engineer a protein-based vaccine that primes killer T cells to respond against infection, providing protection against a model pathogen. The approach shows promise for developing new vaccines against viruses, bacteria, and parasites, as well as cancer vaccines and therapies.
Scientists have developed a new vaccine that uses an anti-idiotype antibody to stimulate the immune system and prevent Chlamydia trachomatis infections, which affect 700 million people worldwide. The vaccine was effective in animal experiments and may be available for humans with further development.
Researchers at Texas A&M University and MedImmune have developed a new vaccine candidate that appears to offer protection against Lyme disease. The vaccine is based on a protein from the Lyme-causing bacterium and has been shown to clear the disease-causing organisms from the body even after infection.